ArticleWorld journal of clinical cases2022

Comment on "Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy".

Konstantinos Argyriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.